Annual SGA
$11.82 M
+$739.70 K+6.67%
December 31, 2023
Summary
- As of February 7, 2025, VRPX annual SGA is $11.82 million, with the most recent change of +$739.70 thousand (+6.67%) on December 31, 2023.
- During the last 3 years, VRPX annual SGA has risen by +$8.92 million (+307.09%).
- VRPX annual SGA is now at all-time high.
Performance
VRPX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$781.00 K
-$721.30 K-48.01%
September 30, 2024
Summary
- As of February 7, 2025, VRPX quarterly SGA is $781.00 thousand, with the most recent change of -$721.30 thousand (-48.01%) on September 30, 2024.
- Over the past year, VRPX quarterly SGA has dropped by -$3.84 million (-83.09%).
- VRPX quarterly SGA is now -84.09% below its all-time high of $4.91 million, reached on September 30, 2022.
Performance
VRPX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$256.74 M
-$13.24 M-5.44%
September 30, 2024
Summary
- As of February 7, 2025, VRPX TTM SGA is -$256.74 million, with the most recent change of -$13.24 million (-5.44%) on September 30, 2024.
- Over the past year, VRPX TTM SGA has dropped by -$265.47 million (-3041.59%).
- VRPX TTM SGA is now -3970.02% below its all-time high of -$6.31 million.
Performance
VRPX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VRPX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | -83.1% | -3041.6% |
| 3 y3 years | +307.1% | -49.7% | -4857.4% |
| 5 y5 years | +696.8% | -49.7% | -4857.4% |
VRPX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.5% | -84.1% | +88.0% | -268.4% | at low |
| 5 y | 5-year | at high | +362.0% | -84.1% | +88.0% | -3970.0% | at low |
| alltime | all time | at high | +696.8% | -84.1% | +88.0% | -3970.0% | at low |
Virpax Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $781.00 K(-48.0%) | $8.81 M(-30.3%) |
| Jun 2024 | - | $1.50 M(-11.1%) | $12.65 M(-3.4%) |
| Mar 2024 | - | $1.69 M(-65.1%) | $13.10 M(+10.8%) |
| Dec 2023 | $11.82 M(+6.7%) | $4.84 M(+4.7%) | $11.82 M(+35.4%) |
| Sep 2023 | - | $4.62 M(+137.1%) | $8.73 M(-3.2%) |
| Jun 2023 | - | $1.95 M(+369.0%) | $9.02 M(-7.2%) |
| Mar 2023 | - | $415.50 K(-76.2%) | $9.72 M(-12.3%) |
| Dec 2022 | $11.08 M | $1.74 M(-64.5%) | $11.08 M(-5.4%) |
| Sep 2022 | - | $4.91 M(+85.6%) | $11.71 M(+40.2%) |
| Jun 2022 | - | $2.65 M(+48.4%) | $8.35 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.78 M(-24.9%) | $7.70 M(+7.1%) |
| Dec 2021 | $7.19 M(+147.5%) | $2.37 M(+52.9%) | $7.19 M(+33.2%) |
| Sep 2021 | - | $1.55 M(-22.0%) | $5.40 M(+15.9%) |
| Jun 2021 | - | $1.99 M(+56.2%) | $4.66 M(+24.9%) |
| Mar 2021 | - | $1.27 M(+118.6%) | $3.73 M(+28.4%) |
| Dec 2020 | $2.90 M(+13.5%) | $582.60 K(-28.1%) | $2.90 M(+2.6%) |
| Sep 2020 | - | $810.70 K(-23.6%) | $2.83 M(+40.1%) |
| Jun 2020 | - | $1.06 M(+136.5%) | $2.02 M(+110.8%) |
| Mar 2020 | - | $449.00 K(-11.8%) | $957.90 K(+88.2%) |
| Dec 2019 | $2.56 M(+72.5%) | $508.90 K | $508.90 K |
| Dec 2018 | $1.48 M | - | - |
FAQ
- What is Virpax Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual SGA year-on-year change?
- What is Virpax Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly SGA year-on-year change?
- What is Virpax Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals TTM SGA year-on-year change?
What is Virpax Pharmaceuticals annual SGA?
The current annual SGA of VRPX is $11.82 M
What is the all time high annual SGA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual SGA is $11.82 M
What is Virpax Pharmaceuticals annual SGA year-on-year change?
Over the past year, VRPX annual SGA has changed by +$739.70 K (+6.67%)
What is Virpax Pharmaceuticals quarterly SGA?
The current quarterly SGA of VRPX is $781.00 K
What is the all time high quarterly SGA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly SGA is $4.91 M
What is Virpax Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, VRPX quarterly SGA has changed by -$3.84 M (-83.09%)
What is Virpax Pharmaceuticals TTM SGA?
The current TTM SGA of VRPX is -$256.74 M
What is the all time high TTM SGA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high TTM SGA is -$6.31 M
What is Virpax Pharmaceuticals TTM SGA year-on-year change?
Over the past year, VRPX TTM SGA has changed by -$265.47 M (-3041.59%)